Radient Pharmaceuticals Corporation fka RXPC

[guardiangel]

DCSPKA YOU SAID
William Gartner

Sunday, 04/13/14 09:09:09 PM
Re: vester_guy post# 20743
Post # of 20748
A brief summary of what William Gartner has been up to:

"William Gartner, whose 8-year-old company (Provista Life Sciences LLC) brought a breast cancer blood test to market in 2009 and is working on similar diagnostics for lung cancer and Alzheimer’s disease. Recently, Gartner sold Phoenix-based Provista Life Sciences LLC’s breast and lung cancer testing technologies to a new company called Provista Diagnostics Inc., which he intends to take public by the middle of next year."

Since then, William has acquired the rights to the Lung Cancer Test thru his company Global Cancer Diagnostics (GCDx), and is trying to acquire the rights to RXPC/Onko Sure to complete the effectiveness of the Lung Cancer Test.

William has licensed out the Alzheimer technology to Amarantus (AMBS) thru his other company Memory DX.

Provista has kept the Breast Cancer Testing. William is currently keeping His Promise to take Provista public thru his M & A prowess by reverse merging into RXPC. Everything will be brought together under the Provista umbrella, and from there will court licensing agreements with Big Pharma (SRL, etc).

Wolf Says

Gold seeker forgot to mention that William was one of the 18 original investors... Here is the Link..

March 1, 2012 18 Investors

http://www.sec.gov/Archives/edgar/data/1539252/000153925212000005/xslFormDX01/primary_doc.xml

http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001539252

September 21, 2012 32 Investors

http://www.sec.gov/Archives/edgar/data/1539252/000153925212000006/xslFormDX01/primary_doc.xml

April 24,2013 35 Investors

http://www.sec.gov/Archives/edgar/data/1539252/000153925213000003/xslFormDX01/primary_doc.xml

Columbo Says "Just One More Thing"


The original 18 investors had to put up 250,000 USD each as an original investment..That is 4,750,000 Dollars you understand..Wolf


Provista Diagnostics Inc.

Industry Biotechnology (See Other Companies in Industry)
17301 N. Perimeter Drive, Suite 100
Scottsdale, AZ, 85085
Phone: [phone]
Filings
Date Filing Type Offered Sold Type Link to Raw Filing
2013-04-24 New Form D Offered: $6,000,000 Sold: $5,999,999 Type: Equity Only Raw Filing
2012-09-21 Amended Offered: $7,485,891 Sold: $7,485,891 Type: Equity Only Raw Filing
2012-03-01 New Form D Offered: $4,950,000 Sold: $4,510,000 Type: Equity Only Raw Filing
Directors and Executives (Current and Past)
Name Role Address
Anne Busquet Director
17301 N. Perimeter Dr., Suite 100
Scottsdale, AZ, 85255
John Fermanis Executive
17301 N. Perimeter Dr., Suite 100
Scottsdale, AZ, 85255
William Gartner Executive
6225 North 24 Th Street, Suite 150
Phoenix, AZ, 85016
Jeffrey Gilman Director
17301 N. Perimeter Dr., Suite 100
Scottsdale, AZ, 85255
Robert Hariri Director
17301 N. Perimeter Dr., Suite 100
Scottsdale, AZ, 85255
Jack Levine Director
17301 N. Perimeter Dr., Suite 100
Scottsdale, AZ, 85255
John Macaskill Director
17301 N. Perimeter Dr., Suite 100
Scottsdale, AZ, 85255
David Reese Director, Executive
17301 N. Perimeter Dr., Suite 100
Scottsdale, AZ, 85255
John Zicarelli Director
17301 N. Perimeter Dr., Suite 100
Scottsdale, AZ, 85255

http://www.formds.com/issuers/provista-diagnostics-inc